Recall record at a glance
| Official record | F-0341-2021 |
|---|---|
| Category | Food Recalls |
| Classification | Class I |
| FDA record status | Terminated |
| Recalling firm | KAREEM MART Inc. |
| Report date | Mar 24, 2021 |
| Recall initiation date | Feb 25, 2021 |
| Quantity | 1800 of the 1lb units; 450 of the 2lb units; and 100 of the 10kg units |
| Location | Garden City, MI, United States |
Official product description
Tahina Sesame Paste packaged in 1lb and 2lb plastic jars and 10kg metal containers; UPC CODES 6215000382207
Why the product was recalled
Product tested positive for Salmonella.
Distribution information
The products covered by this recall may have been distributed to a distributor and retail stores in the following states: Illinois, Montana, Michigan, New York, North Carolina, Ohio, Pennsylvania, and Virginia.
How to read the classification
FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Telephone.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.